AmerisourceBergen (ABC)

30 S&P 500 Stocks That Rose In The Crisis: It’s A Market Of Stocks: Part 1

2020-04-23

Research Articles

Introduction I have long asserted that it is a market of stocks and not a stock market.  Perhaps the veracity of that statement has never been clearer than it is today.  We are all aware of the devastation to the stock market in general that the shutdown instigated by the coronavirus has cost.  However, despite […]

The Top 3 Medical Distributors Are On Sale: AmerisourceBergen, Cardinal Health and McKesson Corp.

2020-01-30

Research Articles

Introduction The top 3 Medical DistributorsAmerisourceBergen (ABC), Cardinal Health (CAH) and McKesson Corp. (MCK) dominate the distribution of pharmaceuticals and are estimated to represent 90% to 95% of the market.  Moreover, each are dividend growth stocks, and as a specific subsector group all appear significantly undervalued.  Therefore, it is reasonable to assume that the issues […]

Building a Dividend Growth Portfolio from Scratch: 15 A Rated or Better Fairly Valued Opportunities

2018-10-17

Research Articles

Introduction We remain in one of the longest bull markets in history.  Generally, with bull markets stocks tend to become highly valued.  Additionally, we also continue to find ourselves in a low interest rate environment based on historical standards.  However, after bottoming out in January 2017, interest rates have steadily increased.  Although interest rates remain […]

10 Fairly Valued Dividend Growth Stocks for Total Return: Part 4

2018-04-18

Research Articles

Introduction This is the fourth of a five-part series presenting 50 dividend growth stocks that I have screened for current fair value. With this article, I will be covering 10 additional dividend growth research candidates with moderate to higher yields in addition to the initial 30 that I presented in part 1 found here, part 2 found […]

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.